Zubsolv Tablet, Orally Disintegrating
Product Images NDC 82111-202

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zubsolv (NDC 82111-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edenbridge Pharmaceuticals Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (0 7mg Carton)

Zubsolv 0.7 mg/0.18 mg sublingual tablets package label in menthol flavor. The label shows the proprietary name Zubsolv, the generic names buprenorphine and naloxone, and dosing instructions including sublingual administration. It indicates a 30 tablet count (10 tablets per card, 3 cards) and features warnings about safe storage and risks to children. The labeler is listed as Dexcel Pharma USA.*

FDA Label Image

1 (1 4mg Carton)

Zubsolv 1.4 mg/0.36 mg sublingual tablets packaging label for buprenorphine hydrochloride and naloxone hydrochloride tablets in menthol flavor. The label indicates 30 tablets (10 tablets x 3 cards) for sublingual use, manufactured by Edenbridge Pharmaceuticals LLC. Instructions and safety warnings are also visible along with barcode and contact information for Dexcel Pharma USA.*

FDA Label Image

1 (11 4mg Carton)

Zubsolv 11.4 mg/2.9 mg sublingual tablets packaging label. This is a menthol flavor, orally disintegrating tablet in a package containing 30 sublingual tablets (10 tablets x 3 cards). Manufactured and distributed by Edenbridge Pharmaceuticals LLC under license from Dexcel Pharma USA. The label includes instructions for use, storage, warnings, and contact information.*

FDA Label Image

1 (2 9mg Carton)

Packaging label for Zubsolv sublingual tablets, containing buprenorphine hydrochloride and naloxone hydrochloride 2.9 mg/0.71 mg. The label indicates menthol flavor and a quantity of 30 sublingual tablets (10 tablets x 3 cards). The labeler is Dexcel Pharma USA. Instructions and storage information are also visible.*

FDA Label Image

1 (5 7mg Carton)

Packaging label for Zubsolv 5.7 mg/1.4 mg sublingual tablets, containing buprenorphine and naloxone. The label indicates menthol flavor and includes instructions for use and safety warnings. It states the package contains 30 sublingual tablets (10 tablets x 3 cards) and is labeled for prescription use by Edenbridge Pharmaceuticals LLC.*

FDA Label Image

1 (8 6mg Carton)

Zubsolv 8.6 mg/2.1 mg sublingual tablets packaging label for buprenorphine hydrochloride and naloxone hydrochloride. The label indicates menthol flavor and includes patient instructions for sublingual administration, safety warnings, and package count of 30 tablets (10 tablets x 3 cards). Manufactured by Dexcel Pharma USA, the label highlights not to cut, crush, break, chew, or swallow the tablets.*

FDA Label Image

1 (Buprenorphine)

Chemical structure of buprenorphine hydrochloride, the active ingredient in Zubsolv tablets. The diagram shows its molecular framework including hydroxyl, methoxy, and tertiary butyl groups, along with the hydrochloride component.*

FDA Label Image

1 (Figure A)

Illustration showing hands tearing open a strip package, likely related to Zubsolv tablets. The image depicts opening a folded foil packaging by pulling apart along a perforated or scored line, demonstrating how to access the orally disintegrating tablet inside.*

FDA Label Image

1 (Figure B)

An instructional illustration showing two hands peeling apart a blister pack, with an arrow indicating the direction to open. The image is labeled Figure B and likely demonstrates how to access individual tablets from packaging.*

FDA Label Image

1 (Figure C)

Instructional illustration showing a close-up of hands peeling the backing paper from an orally disintegrating tablet packaging. The image depicts the removal of a single tablet from its protective foil blister in a step-by-step manner.*

FDA Label Image

1 (Figures D E F)

Instructional diagram showing three steps for taking an orally disintegrating tablet sublingually. Figure D illustrates placing the tablet under the tongue using fingers. Figure E shows the tablet positioned under the tongue. Figure F shows the tongue without the tablet, indicating it has dissolved or been absorbed.*

FDA Label Image

1 (Naloxone)

Chemical structure of buprenorphine hydrochloride dihydrate, an active ingredient in Zubsolv tablets. The diagram shows the molecular arrangement including key functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.